Compare UEIC & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UEIC | ECOR |
|---|---|---|
| Founded | 1986 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.8M | 48.6M |
| IPO Year | 1995 | 2018 |
| Metric | UEIC | ECOR |
|---|---|---|
| Price | $4.14 | $9.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.50 | ★ $18.00 |
| AVG Volume (30 Days) | 44.8K | ★ 112.3K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.78 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $368,288,000.00 | $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $2.69 | $4.16 |
| 52 Week High | $7.50 | $9.68 |
| Indicator | UEIC | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 77.84 |
| Support Level | $4.08 | $4.66 |
| Resistance Level | $4.13 | N/A |
| Average True Range (ATR) | 0.15 | 0.75 |
| MACD | 0.01 | 0.39 |
| Stochastic Oscillator | 47.50 | 87.31 |
Universal Electronics Inc is engaged in universal wireless control solutions for the home. The company design, develop, manufacture, ship and support climate control solutions, wireless sensor and smart home control products, home entertainment control products, technology and software solutions and audio-video (AV) accessories that are used by the world's brands in the climate control, security, home automation, home appliance, home entertainment and consumer electronics markets.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.